About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5478500
Allelic
Composition
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
Genetic
Background
MRL.Cg-Tlr9tm1Aki Faslpr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Faslpr mutation (39 available); any Fas mutation (82 available)
Tlr9tm1Aki mutation (7 available); any Tlr9 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants show accelerated mortality relative to Faslpr homozygotes, with a median survival of 16.4 weeks compared to 25.1 weeks for Faslpr homozygotes

immune system
• splenomegaly is increased more than in Faslpr homozygotes
• 3-fold increase in the number of CD4- CD8- double-negative T cells in the spleen compared to Faslpr homozygotes
• increase in number of CD4+ helper T cells compared to Faslpr homozygotes
• B cells have increased expression of activation markers CD44 and CD69 compared to Faslpr homozygotes, indicating increased B cell activation
• increase in concentration of every IgG isotype compared to Faslpr homozygotes, with most prominent increases in IgG2a and IgG3
• compared to Faslpr homozygotes
• compared to Faslpr homozygotes
• mice exhibit increased serum IFN-alpha concentration compared to Faslpr homozygotes
• lymphadenopathy is increased more than in Faslpr homozygotes
• splenic plasmacytoid dendritic cells (pDC) are more activated than those in single Faslpr homozygotes based on increased expression of MHC class II
• plasmacytoid DCs have an increased expression of the activation markers CD80 and CD86 compared to Faslpr homozygotes
• mutants exhibit an increase in the incidence and severity of autoimmune skin disease compared to single Faslpr homozygous littermates
• mutants develop exacerbated kidney disease (lupus nephritis) compared to single Faslpr homozygotes
• mutants show impaired ability to generate antibodies to DNA antigens compared to single Faslpr homozygotes, however they do generate antibodies reacting with cytoplasmic antigens that may include RNA
• mice exhibit an elevated baseline level of anti-Smith-ribonucleoprotein autoantibodies compared to single Faslpr homozygotes
• mutants develop exacerbated kidney disease (lupus nephritis) compared to Faslpr homozygotes
• a trend towards increased severity of interstitial infiltrates compared to Faslpr homozygotes
• increase in glomerular size, cellularity, and protein deposition in kidneys leading to glomerulonephritis

renal/urinary system
• mutants develop exacerbated kidney disease (lupus nephritis) compared to Faslpr homozygotes
• a trend towards increased severity of interstitial infiltrates compared to Faslpr homozygotes
• increase in glomerular size, cellularity, and protein deposition in kidneys leading to glomerulonephritis
• glomerular size and cellularity are increased compared to Faslpr homozygotes

hematopoietic system
• splenomegaly is increased more than in Faslpr homozygotes
• 3-fold increase in the number of CD4- CD8- double-negative T cells in the spleen compared to Faslpr homozygotes
• increase in number of CD4+ helper T cells compared to Faslpr homozygotes
• B cells have increased expression of activation markers CD44 and CD69 compared to Faslpr homozygotes, indicating increased B cell activation
• increase in concentration of every IgG isotype compared to Faslpr homozygotes, with most prominent increases in IgG2a and IgG3
• compared to Faslpr homozygotes
• compared to Faslpr homozygotes

homeostasis/metabolism
• mice exhibit increased serum IFN-alpha concentration compared to Faslpr homozygotes

growth/size/body
• splenomegaly is increased more than in Faslpr homozygotes


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory